导航引导下整块切除与病灶内刮除治疗局部侵袭性骨肿瘤相比是否有优势?
该回顾性比较研究纳入2010至2014年接受刮除加苯酚辅助治疗(43例可随访)或导航引导下整块切除(26例)的局部侵袭性原发骨肿瘤患者,比较局部复发、非肿瘤并发症和修订版肌肉骨骼肿瘤学会(MSTS)评分。刮除组2例局部复发,整块切除组无局部复发;两组并发症发生率分别为7%(3/43)和4%(1/26),平均MSTS评分分别为28分和29分(p=0.10)。作者认为现有样本量下两组在局部复发风险、并发症或功能方面未见差异,暂不能推荐广泛使用导航引导下整块切除。
要点
- 刮除组2例局部复发,导航引导下整块切除组无局部复发。
- 并发症:刮除组7%(3/43) vs 导航组4%(1/26)。
- 平均MSTS评分:刮除组28分 vs 导航组29分(p=0.10)。
核心结论
- 在这个小型比较系列中,导航辅助切除技术可实现局部侵袭性原发骨肿瘤的保守性整块切除,且无局部复发。
- 然而,就现有样本量而言,两组在局部复发风险、并发症或功能方面未见差异。
- 除非研究证明导航引导下整块切除具有优势,否则作者认为不能推荐广泛使用这一新技术,因其增加手术时间和费用。
研究设计与样本
- 回顾性研究,纳入2010年至2014年间接受刮除加辅助治疗或导航辅助下整块切除的干骺端和/或骨骺局部侵袭性原发骨肿瘤患者。
- 纳入组织学诊断为原发侵袭性良性骨肿瘤或低级别软骨肉瘤的患者。
- 刮除组治疗45例,43例(95%)可随访至少24个月(平均37个月,范围24-61个月);导航引导下整块切除组治疗26例,全部(100%)可随访。
- 当病变与软骨下骨接触时,本研究中心通常行刮除加苯酚治疗;对于距软骨下骨至少5 mm的肿瘤,考虑可行计算机辅助整块切除时行整块切除。
- 两组在年龄、性别、肿瘤类型或肿瘤位置方面无差异。
主要发现
- 刮除组2例出现局部复发,整块切除组无局部复发记录。
- 所有接受导航引导下切除的患者均达到无肿瘤边缘。
- 术中导航在所有患者中成功实施,无配准失败。
- 术后并发症两组无差异:刮除组7%(3/43),导航组4%(1/26)出现并发症。
- 功能评分无差异:刮除组平均MSTS评分28分(范围27-30分),导航组29分(范围27-30分;p=0.10)。
关键数值与推荐
- 骨愈合定义为至少两个不同 radiographic 视图上可见同种异体骨-宿主交界处完全的骨膜和骨内膜桥接,且愈合部位无疼痛和不稳定。
临床怎么用
- 作者认为,除非研究证明导航引导下整块切除具有优势,否则不能推荐广泛使用这一新技术,因其增加手术时间和费用。
- 本研究中心在病变与软骨下骨接触时通常行刮除加苯酚治疗;对于距软骨下骨至少5 mm的肿瘤,考虑可行计算机辅助整块切除时行整块切除。
局限性
- 作者称本研究为小型比较系列。
- 作者指出就现有样本量而言,两组在局部复发风险、并发症或功能方面未见差异。
- 作者认为除非研究证明导航引导下整块切除具有优势,否则不能推荐广泛使用这一新技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of locally aggressive bone tumors is a balance between achieving local tumor control and surgical morbidity. Wide resection decreases the likelihood of local recurrence, although wide resection may result in more complications than would happen after curettage. Navigation-assisted surgery may allow more precise resection, perhaps making it possible to expand the procedure's indications and decrease the likelihood of recurrence; however, to our knowledge, comparative studies have not been performed. QUESTIONS/PURPOSES: The purpose of this study was to compare curettage plus phenol as a local adjuvant with navigation-guided en bloc resection in terms of (1) local recurrence; (2) nononcologic complications; and (3) function as measured by revised Musculoskeletal Tumor Society (MSTS) scores. METHODS: Patients with a metaphyseal and/or epiphyseal locally aggressive primary bone tumor treated by curettage and adjuvant therapy or en bloc resection assisted by navigation between 2010 and 2014 were considered for this retrospective study. Patients with a histologic diagnosis of a primary aggressive benign bone tumor or low-grade chondrosarcoma were included. During this time period, we treated 45 patients with curettage of whom 43 (95%) were available for followup at a minimum of 24 months (mean, 37 months; range, 24-61 months), and we treated 26 patients with navigation-guided en bloc resection, of whom all (100%) were available for study. During this period, we generally performed curettage with phenol when the lesion was in contact with subchondral bone. We treated tumors that were at least 5 mm from the subchondral bone, such that en bloc resection was considered possible with computer-assisted block resection. There were no differences in terms of age, gender, tumor type, or tumor location between the groups. Outcomes, including allograft healing, nonunion, tumor recurrence, fracture, hardware failure, infection, and revised MSTS score, were recorded. Bone consolidation was defined as complete periosteal and endosteal bridging visible between the allograft-host junctions in at least two different radiographic views and the absence of pain and instability in the union site. All study data were obtained from our longitudinally maintained oncology database. RESULTS: In the curettage group, two patients developed a local recurrence, and no local recurrences were recorded in patients treated with en bloc resection. All patients who underwent navigation-guided resection achieved tumor-free margins. Intraoperative navigation was performed successfully in all patients and there were no failures in registration. Postoperative complications did not differ between the groups: in patients undergoing curettage, 7% (three of 43) and in patients undergoing navigation, 4% (one of 26) had a complication. There was no difference in functional scores: mean MSTS score for patients undergoing curettage was 28 points (range, 27-30 points) and for patients undergoing navigation, 29 (range, 27-30 points; p = 0.10). CONCLUSIONS: In this small comparative series, navigation-assisted resection techniques allowed conservative en bloc resection of locally aggressive primary bone tumors with no local recurrence. Nevertheless, with the numbers available, we saw no difference between the groups in terms of local recurrence risk, complications, or function. Until or unless studies demonstrate an advantage to navigation-guided en bloc resection, we cannot recommend wide use of this novel technique because it adds surgical time and expense. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Farfalli GL, Albergo JI, Piuzzi NS, et al. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors? Clin Orthop Relat Res. 2018. PMID: 29529633. doi:10.1007/s11999.0000000000000054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。